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OCT Versus IVUS: Accuracy Versus Clinical Utility*
Akiko Maehara, MD,yz Gary S. Mintz, MD,z Gregg W. Stone, MDyz
New York, New YorkThe technology of optical coherence tomography
(OCT) has evolved from time-domain to frequency-
domain imaging. Time-domain OCT is most often
performed using proximal balloon occlusion; as such,
dimensions are smaller than measured using intra-
vascular ultrasound (IVUS), presumably due to
diminished perfusion pressure. Conversely,
frequency-domain OCT does not require proximal
balloon occlusion, theoretically resulting in more
accurate measurements.See page 1095With this background, Kubo et al. (1) in this
issue of iJACC, conducted a multicenter study to
compare pre-intervention quantitative analysis
and post-intervention qualitative analysis among
frequency-domain OCT, IVUS, and quantitative
coronary angiography (QCA). The mean minimum
lumen diameter measured by QCA was smaller than
by OCT, which was smaller than that by IVUS
(1.81  0.72 mm vs. 1.91  0.69 mm vs.
2.09  0.60 mm, respectively). The minimum
lumen area measured by using IVUS was signiﬁ-
cantly greater than that according to frequency-
domain OCT (3.68 mm2 vs. 3.27 mm2; p < 0.001).
Both techniques exhibited good interobserver
reproducibility in a core laboratory setting. The
lumen area by frequency-domain OCT was equal to*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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ration, InfraReDx, and Boston Scientiﬁc.the lumen areas of phantom models whereas IVUS
overestimated phantom model lumen areas (8.03
mm2 vs. 7.45 mm2; p < 0.001). Not surprisingly,
OCT detected tissue protrusion (95%), incomplete
stent malapposition (39%), dissection (13%), and
thrombus (13%) much more frequently than did
IVUS.
The data presented by Kubo et al. (1) are
consistent with previous reports (2–6) except that
the mean difference in lumen area between IVUS
versus phantoms (0.58 mm2) was the largest among
published studies. In previous studies, when OCT
and IVUS were compared in vivo, the mean differ-
ences in lumen area varied from 0.19 mm2 to
1.15 mm2 and were consistently larger using IVUS
than using OCT, especially in smaller lumens and in
nonstented segments. Nonetheless, the integrated
performance of both a bench and clinical study is a
strength of the current report, and establishes that
IVUS overestimates and QCA underestimates cor-
onary diameter measurements (each by approxi-
mately 5% in vivo), with frequency domain OCT
closest to “the truth.”
Although measurement accuracy is inherently
desirable, even more fundamental clinical questions
remain. First, what are the quantitative and quali-
tative OCT predictors of adverse events after bare-
metal or drug-eluting stent (DES) implantation?
Are they the same or different from IVUS? And,
therefore, how should OCT be used to guide stent
implantation? Second, does OCT guidance of cor-
onary stent implantation reduce adverse events
compared with angiography alone? Which is supe-
rior to guide stent procedures, OCT or IVUS? In
this regard, the essential properties of OCT and
IVUS are so different that dimensional accuracy is
only the beginning of the story.
What are the advantages of IVUS? 1) IVUS has
been used clinically for nearly 3 decades. 2) Pre-
intervention IVUS imaging is almost always possible
without pre-dilation. 3) Ultrasound penetration to
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1106the adventitia allows measurement of the true vessel
size (external elastic membrane) and plaque burden,
facilitating mid-wall or true vessel stent sizing to
optimize stent dimensions and identifying a landing
zone with the smallest plaque burden to minimize
geographical miss. 4) IVUS predictors of stent failure
(stent underexpansion, major edge dissections, and
geographicmiss but not acutemalapposition) are well
established. 5) A meta-analysis of 7 randomized
IVUS versus angiography-guided bare metal stent
implantation trials found that IVUSguidance reduces
restenosis and repeat revascularizationwith no impact
on death or myocardial infarction (7). 6) A meta-
analysis of 11 IVUS versus angiography-guided
DES studies found that IVUS guidance is associ-
ated with a reduced incidence of death, major adverse
cardiac events, and stent thrombosis (8). This latter
meta-analysis is supported by a recently published
randomized trial (RESET [Real Safety and Efﬁcacy
of a 3-Month Dual Antiplatelet Therapy Following
Zotarolimus-Eluting Stents Implantation]) from
South Korea (9) as well as by a large-scale prospective
observational study (ADAPT-DES [Assessment
of Dual AntiPlatelet Therapy with Drug-Eluting
Stents]) in more than 8,500 patients (10).
What are the advantages of OCT, especially
compared with IVUS? 1) The resolution of OCT is
10 times greater than IVUS such that OCT detects
ﬁne details missed by IVUS (e.g., edge dissections,
small amounts of malapposition, tissue protrusion,
stent strut coverage, ﬁbrous cap thickness), as shown
both in the study by Kubo et al. (1) and by others. 2)
OCT tissue characterization is better, and OCT
may be the gold standard for thrombus detection. 3)
The images are clearer and easier to interpret, in
part because the obligatory ﬂushing clears the lumen
of blood. 4) Rapid automated pullback afforded by
OCT minimizes ischemia. 5) One published study
by Prati et al. (11) found that OCT-guided DES
implantation may be better than angiographic
guidance; OCT reduced repeat revascularization,
myocardial infarction, and cardiac death.
The major drawback of OCT is lack of depth
penetration. As such, the external elasticmembrane and extent of plaque burden cannot
typically be measured. Thus, with OCT proce-
dural guidance, stent diameters are chosen to
match the reference lumen (potentially resulting
in smaller stent areas than with IVUS guid-
ance), and avoiding geographic miss may be
more difﬁcult with OCT than with IVUS.
Do the advantages of OCT from its enhanced
resolution outweigh these limitations? More
than 20 years of experience using IVUS have
shown that small amounts of tissue protrusion,
minor edge dissections, and acute stent malap-
position do not correlate with adverse outcomes
as long as the minimum stent area is sufﬁcient
(12). A small randomized trial (n ¼ 70)
comparing OCT versus IVUS guidance showed
that the ﬁnal minimum stent area was signiﬁ-
cantly smaller after OCT guidance compared
with IVUS guidance (6.1 mm2 vs. 7.1 mm2;
p < 0.05), with a larger plaque burden at the
distal stent edge after OCT guidance (13). In
other words, there was greater stent under-
expansion and more geographic miss with OCT
than with IVUS.
Kubo et al. (1) have established that OCT has
greater measurement accuracy than IVUS. Whether
OCT is superior to (or as good as) IVUS in
improving clinical outcomes when used to guide
coronary intervention will only be answered by an
adequately powered randomized trial. Given the
excellent results with contemporary DES, a very
large (and expensive) trial would be required to
detect relatively small differences. Conversely, given
the fact that more than 4 million DES are
implanted globally each year, can we afford not to
identify the best way to optimize patient outcomes?
Until such a trial is complete, it is likely that the
OCT versus IVUS debate will continue.
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